| RS207482233 |
CYP4V2
|
Health Risk |
Pathogenic |
Bietti crystalline corneoretinal dystrophy, Retinal dystrophy |
| RS2074872521 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2074888 |
TCF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myeloproliferative neoplasm, unclassifiable |
| RS2074897929 |
CASR
|
Health Risk |
Likely pathogenic |
Autosomal dominant hypocalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS2074912574 |
IFT122
|
Health Risk |
Likely pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2074920676 |
CASR
|
Health Risk |
Likely pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074923990 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074924614 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074926028 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074926931 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074927550 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia, Familial hypocalciuric hypercalcemia |
| RS2074927630 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074932551 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS2074934463 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074935748 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074937924 |
CASR
|
Health Risk |
Likely pathogenic |
— |
| RS2074938472 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS2074940195 |
CASR
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2074944872 |
GPI
|
Health Risk |
Pathogenic |
— |
| RS2074944986 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS2074949880 |
CNOT3
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy with developmental delay, Moyamoya angiopathy with developmental delay |
| RS2074950882 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074970792 |
PRCD
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2074971229 |
SOX5
|
Health Risk |
Pathogenic |
— |
| RS2074979029 |
PRCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2074979676 |
CYGB;PRCD
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 36, Retinitis pigmentosa 36 |
| RS2074997790 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075001826 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2075018501 |
DNAH9
|
Health Risk |
Likely pathogenic |
— |
| RS2075058462 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2075071528 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2075071667 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS2075088671 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2075090666 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Alternating hemiplegia of childhood 2 |
| RS2075127396 |
TMC8
|
Health Risk |
Likely pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2075158686 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2075158829 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Alternating hemiplegia of childhood 2 |
| RS2075159021 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Developmental and epileptic encephalopathy 99 |
| RS2075160048 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075161300 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075161459 |
SMCHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Inborn genetic diseases |
| RS2075161499 |
SMCHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075181080 |
DHDDS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS2075181154 |
DHDDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Retinitis pigmentosa 59 |
| RS2075190697 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS2075199553 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Inborn genetic diseases |
| RS2075207934 |
INPP5K
|
Health Risk |
Likely pathogenic |
Congenital muscular dystrophy with cataracts and intellectual disability, Congenital muscular dystrophy with cataracts and intellectual disability |
| RS2075208108 |
CNOT3
|
Health Risk |
Pathogenic |
— |
| RS2075210211 |
UBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2075211884 |
UBA2
|
Health Risk |
Likely pathogenic |
ACCES syndrome, ACCES syndrome |
| RS2075214464 |
RSPRY1
|
Health Risk |
Pathogenic |
Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome, Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome |
| RS2075237136 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS2075237416 |
ATP1A3
|
Health Risk |
Likely pathogenic |
ATP1A3-associated neurological disorder, ATP1A3-associated neurological disorder |
| RS2075242496 |
UBA2
|
Health Risk |
Likely pathogenic |
— |
| RS2075263105 |
INPP5K
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy with cataracts and intellectual disability, Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| RS2075270806 |
TMC8
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2075273330 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2075276177 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2075282065 |
DHDDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS2075282510 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Inborn genetic diseases |
| RS2075284959 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 99, Developmental and epileptic encephalopathy 99 |
| RS2075291 |
APOA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertriglyceridemia 1, Cardiovascular phenotype |
| RS2075307655 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075308386 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075318017 |
MFF
|
Health Risk |
Pathogenic |
Encephalopathy due to defective mitochondrial and peroxisomal fission 2, Encephalopathy due to defective mitochondrial and peroxisomal fission 2 |
| RS2075320961 |
TMPRSS15
|
Health Risk |
Pathogenic |
— |
| RS2075357811 |
INPP5K
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy with cataracts and intellectual disability, Congenital muscular dystrophy with cataracts and intellectual disability |
| RS2075369142 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2075389484 |
ARL2BP
|
Health Risk |
Likely pathogenic |
— |
| RS2075396572 |
SMCHD1
|
Health Risk |
Pathogenic |
Muscular atrophy, Muscular atrophy |
| RS2075426780 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2075434480 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS2075445039 |
TMPRSS15
|
Health Risk |
Pathogenic |
— |
| RS2075452756 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2075455200 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS2075459852 |
SLC24A1
|
Health Risk |
Pathogenic |
— |
| RS2075473390 |
TMPRSS15
|
Health Risk |
Pathogenic |
— |
| RS2075478466 |
UBA2
|
Health Risk |
Pathogenic |
Chromosome 19q13.11 deletion syndrome, distal |
| RS2075555029 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2075564475 |
TTN
|
Health Risk |
Likely pathogenic |
Early-onset myopathy with fatal cardiomyopathy, Hypertrophic cardiomyopathy 9 |
| RS2075566961 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2075586377 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075587887 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075588188 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Inborn genetic diseases |
| RS2075588362 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075591559 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075591576 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075607 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2075619600 |
UBA2
|
Health Risk |
Likely pathogenic |
ACCES syndrome, ACCES syndrome |
| RS2075650925 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2075651835 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075652085 |
SMC1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075652654 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile nephropathic cystinosis, Inborn genetic diseases |
| RS2075664229 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075680107 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075680329 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Thyroid cancer |
| RS2075681060 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075685944 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS2075686139 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075687166 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |